Diversity-oriented synthesis: Exploring the intersections between chemistry and biology

Nature Chemical Biology

Volumn 1, Issue 2, 2005, Pages 74-84

  Tan, Derek S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ANIMAL; BIOLOGY; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; GENETICS; METABOLISM; METHODOLOGY; ORGANIC CHEMISTRY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGY; CHEMISTRY, ORGANIC; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; PROTEINS; SIGNAL TRANSDUCTION;

EID: 33644839988     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio0705-74     Document Type: Review

References (86)

1. Potuzak, J.S., Moilanen, S.B. & Tan, D.S. Discovery and applications of small molecule probes for studying biological processes. Biotechnol. Genet. Eng. Rev. 21, 11-78 (2004).
2. Schreiber, S.L. The small-molecule approach to biology. Chem. Eng. News 81, 51-61 (3 Mar 2003).
3. Peterson, J.R. & Mitchison, T.J. Small molecules, big impact. A history of chemical inhibitors and the cytoskeleton. Chem. Biol. 9, 1275-1285 (2002).
4. Flaumenhaft, R. & Sim, D.S. The platelet as a model for chemical genetics. Chem. Biol. 10, 481-486 (2003).
5. MacRae, C.A. & Peterson, R.T. Zebrafish-based small molecule discovery. Chem. Biol. 10, 901-908 (2003).
6. Koh, B. & Crews, C.M. Chemical genetics: a small molecule approach to neurobiology. Neuron 36, 563-566 (2002).
7. Walters, W.P. & Namchuk, M. Designing screens: how to make your hits a hit. Nat. Rev. Drug Discov. 2, 259-266 (2003).
8. Feher, M. & Schmidt, J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 43, 218-227 (2003).
9. Haggarty, S.J. The principle of complementarity: chemical versus biological space. Curr. Opin. Chem. Biol. 9, 296-303 (2005).
10. Merrifield, R.B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85, 2149-2154 (1963).
11. Tzschucke, C.C. et al. Modern separation techniques for efficient workup in organic synthesis. Angew. Chem. Int. Ed. Engl. 41, 3964-4000 (2002).
12. Chen, J.K. & Schreiber, S.L. Combinatorial synthesis and multidimensional NMR spectroscopy: an approach to understanding protein-ligand interactions. Angew. Chem. Int. Ed. Engl. 34, 953-969 (1995).
13. Liu, D.R. & Schultz, P.G. Generating new molecular function: a lesson from nature. Angew. Chem. Int. Ed. Engl. 38, 37-54 (1999).
14. Furka, Á., Sebestyén, F., Asgedom, M. & Dibó, G. General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein Res. 37, 487-493 (1991).
15. Lam, K.S. et al. A new type of synthetic peptide library for identifying ligand-binding activity. Nature 354, 82-84 (1991).
16. Burdine, L. & Kodadek, T. Target identification in chemical genetics: the (often) missing link. Chem. Biol. 11, 593-597 (2004).
17. Zheng, X.S., Chan, T.-F., Zhou, H.H. Genetic and genomic approaches to identify and study the targets of bioactive small molecules. Chem. Biol. 11, 609-618 (2004).
18. Mitsopoulos, G., Walsh, D.P. & Chang, Y.-T. Tagged library approach to chemical genomics and proteomics. Curr. Opin. Chem. Biol. 8, 26-32 (2004).
19. Erlanson, D.A., McDowell, R.S. & O'Brien, T. Fragment-based drug discovery. J. Med. Chem. 47, 3463-3482 (2004).
20. Shoichet, B.K. Virtual screening of chemical libraries. Nature 432, 862-865 (2004).
21. Kitchen, D.B., Decornez, H., Furr, J.R. & Bajorath, J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov. 3, 935-949 (2004).
22. Dobson, C.M. Chemical space and biology. Nature 432, 824-828 (2004).
23. Bohacek, R.S., McMartin, C. & Guida, W.C. The art and practice of structure-based drug design: a molecular modeling perspective. Med. Res. Rev. 16, 3-50 (1996).
24. Selzer, P., Roth, H.-J., Ertl, P. & Schuffenhauer, A. Complex molecules: do they add value? Curr. Opin. Chem. Biol. 9, 310-316 (2005).
25. Newman, D.J., Cragg, G.M. & Snader, K.M. Natural products as sources of new drugs over the period 1981–2002. J. Nat. Prod. 66, 1022-1037 (2003).
26. Evans, B.E. et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 31, 2235-2246 (1988).
27. DeSimone, R.W., Currie, K.S., Mitchell, S.A., Darrow, J.W. & Pippin, D.A. Privileged structures: applications in drug discovery. Comb. Chem. High Throughput Screen. 7, 473-493 (2004).
28. Balamurugan, R., Dekker, F.J., Waldmann, H. Design of compound libraries based on natural product scaffolds and protein structure similarity clustering (PSSC). Mol. Biosys. 1, 36-45 (2005).
29. Horton, D.A., Bourne, G.T. & Smythe, M.L. The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem. Rev. 103, 893-930 (2003).
30. Lajiness, M.S., Vieth, M. & Erickson, J. Molecular properties that influence oral drug-like behavior. Curr. Opin. Drug Discov. Dev. 7, 470-477 (2004).
31. Veber, D.F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615-2623 (2002).
32. Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25 (1997).
33. Kahne, D., Leimkuhler, C., Lu, W. & Walsh, C. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 105, 425-448 (2005).
34. Arkin, M.R. & Wells, J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat. Rev. Drug Discov. 3, 301-317 (2004).
35. Pagliaro, L. et al. Emerging classes of protein-protein interaction inhibitors and new tools for their development. Curr. Opin. Chem. Biol. 8, 442-449 (2004).
36. Lepourcelet, M. et al. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex. Cancer Cell 5, 91-102 (2004).
37. Shang, S. & Tan, D.S. Advancing chemistry and biology through diversity-oriented syn-thesis of natural product-like libraries. Curr. Opin. Chem. Biol. 9, 248-258 (2005).
38. Tan, D.S. Current progress in natural product-like libraries for discovery screening. Comb. Chem. High Throughput Screen. 7, 631-643 (2004).
39. Fergus, S., Bender, A. & Spring, D.R. Assessment of structural diversity in combinatorial synthesis. Curr. Opin. Chem. Biol. 9, 304-309 (2005).
40. Xue, L., Stahura, F.L. & Bajorath, J. Cell-based partitioning. Methods Mol. Biol. 275, 279-289 (2004).
41. Haggarty, S.J., Clemons, P.A. & Schreiber, S.L. Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations. J. Am. Chem. Soc. 125, 10543-10545 (2003).
42. Haggarty, S.J., Koeller, K.M., Wong, J.C., Butcher, R.A. & Schreiber, S.L. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. Chem. Biol. 10, 383-396 (2003).
43. Kim, Y-k. et al. Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. J. Am. Chem. Soc. 126, 14740-14745 (2004).
44. Wipf, P., Kendall, C. & Stephenson, C.R.J. Dimethylzinc-mediated additions of alkenyl-zirconocenes to aldimines. New methodologies for allylic amine and C-cyclopropylal- kylamine syntheses. J. Am. Chem. Soc. 125, 761-768 (2003).
45. Wipf, P., Stephenson, C.R.J. & Walczak, M.A.A. Diversity-oriented synthesis of azaspirocycles. Org. Lett. 6, 3009-3012 (2004).
46. Itami, K., Mineno, M., Muraoka, N. & Yoshida, J. Sequential assembly strategy for tetrasubstituted olefin synthesis using vinyl 2-pyrimidyl sulfide as a platform. J. Am. Chem. Soc. 126, 11778-11779 (2004).
47. Itami, K., Kamei, T. & Yoshida, J. Diversity-oriented synthesis of tamoxifen-type tetra- substituted olefins. J. Am. Chem. Soc. 125, 14670-14671 (2003).
48. Pulici, M., Cervi, G., Martina, K. & Quartieri, F. Use of multicomponent, domino, and other one-pot syntheses on solid phase: powerful tools for the generation of libraries of diverse and complex compounds. Comb. Chem. High Throughput Screen. 6, 693-727 (2003).
49. Young, I.S. & Kerr, M.A. A homo [3 + 2] dipolar cycloaddition: the reaction of nitrones with cyclopropanes. Angew. Chem. Int. Ed. Engl. 42, 3023-3026 (2003).
50. Young, I.S. & Kerr, M.A. Three-component homo 3+2 dipolar cycloaddition. A diversity-oriented synthesis of tetrahydro-1, 2-oxazines and FR900482 skeletal congeners. Org. Lett. 6, 139-141 (2004).
51. Tailor, J. & Hall, D.G. Tandem aza[4 + 2]/allylboration: a novel multicomponent reaction for the stereocontrolled synthesis of α-hydroxyalkyl piperidine derivatives. Org. Lett. 2, 3715-3718 (2000).
52. Toure, B.B., Hoveyda, H.R., Tailor, J., Ulaczyk-Lesanko, A. & Hall, D.G. A three-com-ponent reaction for diversity-oriented synthesis of polysubstituted piperidines: solution and solid-phase optimization of the first tandem aza[4+2]/allylboration. Chem. Eur. J. 9, 466-474 (2003).
53. Burke, M.D. & Schreiber, S. L. A planning strategy for diversity-oriented synthesis. Angew. Chem. Int. Ed. Engl. 43, 46-58 (2004).
54. Sutherlin, D.P. & Armstrong, R.W. Synthesis of 12 stereochemically and structurally diverse C-trisaccharides. J. Org. Chem. 62, 5267-5283 (1997).
55. Annis, D.A., Helluin, O. & Jacobsen, E.N. Stereochemistry as a diversity element: Solid-phase synthesis of cyclic RGD peptide derivatives by asymmetric catalysis. Angew. Chem. Int. Ed. Engl. 37, 1907-1909 (1998).
56. Harrison, B.A., Gierasch, T.M., Neilan, C., Pasternak, G.W. & Verdine, G.L. High-affinity mu opioid receptor ligands discovered by the screening of an exhaustively stereodiversified library of 1, 5-enediols. J. Am. Chem. Soc. 124, 13352-13353 (2002).
57. Taylor, S.J., Taylor, A.M. & Schreiber, S.L. Synthetic strategy toward skeletal diversity via solid-supported, otherwise unstable reactive intermediates. Angew. Chem. Int. Ed. Engl. 43, 1681-1685 (2004).
58. Oguri, H. & Schreiber, S.L. Skeletal diversity via a folding pathway: synthesis of indole alkaloid-like skeletons. Org. Lett. 7, 47-50 (2005).
59. Stockwell, B.R., Haggarty, S.J. & Schreiber, S.L. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6, 71-83 (1999).
60. Kuruvilla, F.G., Shamji, A.F., Sternson, S.M., Hergenrother, P.J. & Schreiber, S.L. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 416, 653-657 (2002).
61. Sternson, S.M., Louca, J.B., Wong, J.C. & Schreiber, S.L. Split-pool synthesis of 1, 3-dioxanes leading to arrayed stock solutions of single compounds sufficient for multiple phenotypic and protein-binding assays. J. Am. Chem. Soc. 123, 1740-1747 (2001).
62. Walsh, D.P. & Chang, Y.T. Recent advances in small molecule microarrays: applications and technology. Comb. Chem. High Throughput Screen. 7, 557-564 (2004).
63. Haggarty, S.J., Koeller, K.M., Wong, J.C., Grozinger, C.M. & Schreiber, S.L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. USA 100, 4389-4394 (2003).
64. Wong, J.C., Hong, R. & Schreiber, S.L. Structural biasing elements for in-cell histone deacetylase paralog selectivity. J. Am. Chem. Soc. 125, 5586-5587 (2003).
65. Marks, P.A., Miller, T. & Richon, V.M. Histone deacetylases. Curr. Opin. Pharmacol. 3, 344-351 (2003).
66. McLaughlin, F. & La Thangue, N.B. Histone deacetylase inhibitors open new doors in cancer therapy. Biochem. Pharmacol. 68, 1139-1144 (2004).
67. Sternson, S.M., Wong, J.C., Grozinger, C.M. & Schreiber, S.L. Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org. Lett. 3, 4239-4242 (2001).
68. Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458 (2002).
69. Ding, S. & Schultz, P.G. A role for chemistry in stem cell biology. Nat. Biotechnol. 22, 833-840 (2004).
70. Ding, S., Gray, N.S., Wu, X., Ding, Q. & Schultz, P.G. A combinatorial scaffold approach toward kinase-directed heterocycle libraries. J. Am. Chem. Soc. 124, 1594-1596 (2002).
71. Ding, S. et al. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. USA 100, 7632-7637 (2003).
72. Wu, X., Ding, S., Ding, Q., Gray, N.S. & Schultz, P.G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc. 126, 1590-1591 (2004).
73. Wu, X., Ding, S., Ding, Q., Gray, N.S. & Schultz, P.G. A small molecule with osteogen- esis-inducing activity in multipotent mesenchymal progenitor cells. J. Am. Chem. Soc. 124, 14520-14521 (2002).
74. Chen, S., Zhang, Q., Wu, X., Schultz, P.G. & Ding, S. Dedifferentiation of lineage-com-mitted cells by a small molecule. J. Am. Chem. Soc. 126, 410-411 (2004).
75. Nicolaou, K.C. et al. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries. Org. Biomol. Chem. 1, 908-920 (2003).
76. Downes, M. et al. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol. Cell 11, 1079-1092 (2003).
77. Nicolaou, K.C. et al. Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using NanoKans and optical encoding. J. Am. Chem. Soc. 122, 9954-9967 (2000).
78. Boger, D.L., Desharnais, J. & Capps, K. Solution-phase combinatorial libraries: Modulating cellular signaling by targeting protein-protein or protein-DNA interactions. Angew. Chem. Int. Ed. Engl. 42, 4138-4176 (2003).
79. Boger, D.L., Lee, J.K., Goldberg, J. & Jin, Q. Two comparisons of the performance of positional scanning and deletion synthesis for the identification of active constituents in mixture combinatorial libraries. J. Org. Chem. 65, 1467-1474 (2000).
80. Berg, T. et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 99, 3830- 3835 (2002).
81. Koehler, A.N., Shamji, A.F. & Schreiber, S.L. Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. J. Am. Chem. Soc. 125, 8420-8421 (2003).
82. Yin, X., Giap, C., Lazo, J.S. & Prochownik, E.V. Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 22, 6151-6159 (2003).
83. Austin, C.P., Brady, L.S., Insel, T.R. & Collins, F.S. Policy forum: molecular biology: NIH molecular libraries initiative. Science 306, 1138-1139 (2004).
84. Walsh, D., Wu, D. & Chang, Y.-T. Understanding the effects of the polymer support on reaction rates and kinetics: knowledge toward efficient synthetic design. Curr. Opin. Chem. Biol. 7, 353-361 (2003).
85. Affleck, R.L. Solutions for library encoding to create collections of discrete compounds. Curr. Opin. Chem. Biol. 5, 257-263 (2001).
86. Ertl, P., Rohde, B. & Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43, 3714-3717 (2000).